Related references
Note: Only part of the references are listed.Essential Domains of A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13 Metalloprotease Required for Modulation of Arterial Thrombosis
Juan Xiao et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency
E. Ayuso et al.
GENE THERAPY (2010)
The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo
B. De Maeyer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation
Fumiaki Banno et al.
BLOOD (2009)
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy
Glenn P. Niemeyer et al.
BLOOD (2009)
Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy
Pablo Laje et al.
BLOOD (2009)
Adenoviral-mediated gene transfer restores plasma ADAMTS13 antigen and activity in ADAMTS13 knockout mice
P. Trionfini et al.
GENE THERAPY (2009)
Correction of ADAMTS13 Deficiency by In Utero Gene Transfer of Lentiviral Vector encoding ADAMTS13 Genes
Masami Niiya et al.
MOLECULAR THERAPY (2009)
Pathogenesis of thrombotic microangiopathies
X. Long Zheng et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Safety and efficacy of gene transfer for Leber's congenital amaurosis
Albert M. Maguire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura
F Banno et al.
BLOOD (2006)
Systemic antithrombotic effects of ADAMTS13
AK Chauhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome - III. An additional study of 57 consecutive patients, 2002-2005
MA Howard et al.
TRANSFUSION (2006)
Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice
DG Motto et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Quantification of adeno-associated virus particles and empty capsids by optical density measurement
JM Sommer et al.
MOLECULAR THERAPY (2003)
Mutations and common polymorphisms in ADAMTS13 gene responsiblefor von Willebrand factor-cleaving protease activity
K Kokame et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
GG Levy et al.
NATURE (2001)
Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome:: the role of von Willebrand factor-cleaving protease
M Furlan et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2001)
Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver
LL Wang et al.
MOLECULAR THERAPY (2000)
Share Paper
